MedTrace Logo

Role of Hazelnut Consumption in Improving Micronutrient Status in Older Adults

NCT03485989 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2019-08-28

No results posted yet for this study

Summary

With advancing age, older adults are susceptible to vitamin and mineral deficiencies for a variety of reasons. Nutrient-dense food sources of vitamin E and other key vitamins and minerals, like hazelnuts, may offer a simple means of improving nutritional status of healthy older adults.

This hypothesis is that individuals eating hazelnuts everyday will result in measurable increases in magnesium and vitamin E levels, two under-consumed micronutrients among older adults. Thus, subjects will consume two ounces (56 g) of hazelnuts each day for sixteen weeks. Investigators will measure vitamin E and magnesium levels along with a general assessment of micronutrient status as primary outcomes. Since nuts are nutrient-rich sources of unsaturated fatty acids but low in carbohydrates, changes in fasting glucose, lipid and lipoprotein profiles, and BMI will also be determined (secondary outcomes).

Conditions

  • Nutrition Poor
  • Micronutrient Deficiency
  • Aging

Interventions

OTHER

Hazelnuts

Dry roasted, individually packaged hazelnuts provided from the Hazelnuts Marketing Board of Oregon

Sponsors & Collaborators

  • Hazelnut Marketing Board

    collaborator UNKNOWN

  • Oregon State University

    lead OTHER

Principal Investigators

  • Maret G Traber, PhD · Oregon State University

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-22
Primary Completion
2017-09-18
Completion
2017-12-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03485989 on ClinicalTrials.gov